Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 228 results for "vldl"

Capstone Therapeutics Announces Patent Application for Novel, More Potent Chimeric Apo E Mimetic Peptides
SPi World News

Capstone Therapeutics Announces Patent Application for Novel, ...

TEMPE, Ariz., July 23, 2015 (GLOBE NEWSWIRE) -- Capstone Therapeutics Corp. ( OTCQB:CAPS ) ("the Company") and its joint venture affiliate, LipimetiX Development, Inc. ("JV"), announced today the conversion of a provisional U.S. Patent application ... BioSpace, 5 days ago

4 images for vldl

MDLinx, 2 weeks ago
Indian Express, 1 month ago
MDLinx, 2 months ago
Boca Raton Magazine, 5 months ago

Reelin in Aβ Damage?

The reelin protein plays a starring role in neural development, and new findings suggest the neuromodulator does an important job in older animals, too. Researchers led by Joachim Herz at the University of Texas Southwestern Medical Center in Dallas ...
 Alzheimer Research Forum1 week ago

Identification of Laying-Related SNP Markers in Geese Using RAD Sequencing

Abstract Laying performance is an important economical trait of goose production. As laying performance is of low heritability, it is of significance to develop a marker-assisted selection (MAS) strategy for this trait. Definition of sequence ...
 Plosone.org1 week ago

Cholesterol Ester Transfer Protein Inhibition by TA-8995

Summary and Comment | July 2, 2015 Karol E. Watson, MD, PhD, FACC reviewing Hovingh GK et al. Lancet 2015 Jun 2. Ray KK and Vallejo-Vaz AJ. Lancet 2015 Jun 2. Karol E. Watson, MD, PhD, FACC A phase 2 study helps ...
 New England Journal of Medicine1 week ago

REGENERON PHARMACEUTICALS : Findings on Lipid Research Reported by Investigators at Regeneron Pharmaceuticals Inc. (Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride...

Findings on Lipid Research Reported by Investigators at Regeneron Pharmaceuticals Inc. (Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion) By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Lipid ...
 4 Traders1 week ago

Intradomain Confinement of Disulfides in the Folding of Two Consecutive Modules of the LDL Receptor

by Juan Martínez-Oliván, Hugo Fraga, Xabier Arias-Moreno, Salvador Ventura, Javier Sancho The LDL receptor internalizes circulating LDL and VLDL particles for degradation. Its extracellular binding domain contains ten (seven LA and three EGF) ...
 Plosone.org2 weeks ago

Up-Regulation Mttp and Apob Gene Expression in Rat Liver is Related to Post-Lipectomy Hypertriglyceridemia

American Academy of Cosmetic Surgery (AACS): 2006 Guidelines for Liposuction Surgery. In: 2006: A joint Ad Hoc Committee of the American Society of Lipo-Suction Surgery (ASLSS) and the American Academy of Cosmetic Surgery 2006.
 Cellular Physiology and Biochemistry2 weeks ago

Premarket Biotech Digest: Eli Lilly's Necitumumab, A Focus On Amgen

Jul. 10, 2015 8:19 AM ET | About: Amgen Inc. (AMGN), Includes: CAPS, CCXI, IPSEF, JNJ, LLY, MRK, SNY by: Kanak Kanti De Summary The FDA advisory committee on Eli Lilly's Necitumumab met yesterday, but hasn't voted yet. Amgen is closer to ...
 Seeking Alpha2 weeks ago

Marker associated with non-alcoholic steatohepatitis

Disclosed is a novel NASH marker for use in a method for detecting NASH or evaluating the severity of NASH, which utilizes at least one factor selected from the group consisting of an IL-1 receptor antagonist, sCD40, HMGB1, sPLA2 group IIA and an ...
 PharmCast2 weeks ago
Tamar Securities

Akcea Therapeutics receives orphan drug designation from FDA for FCS drug

Akcea Therapeutics, a developer of RNA-targeted antisense therapeutics, has received orphan drug designation from the FDA for volanesorsen for the treatment of patients with familial chylomicronemia syndrome, or FCS. In a Phase II study published in ...
 Individual.com2 weeks ago Akcea gets FDA orphan drug status for volanesorsen to treat familial chylomicronemia syndrome  Pharmaceutical Business Review3 weeks ago US FDA grants orphan drug status to Akcea Therapeutics' volanesorsen to treat familial chylomicronemia syndrome  PharmaBiz3 weeks ago Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen  News-Medical.Net3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less